Lecanemab-Irmb
19 interactions 1 explained in plain English
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 11, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Apixaban
Heparin
Dabigatran
Dabigatran Etexilate
Heparin Injection
Fondaparinux Injection
Major
Lecanemab-Irmb Apixaban Eliquis Explained An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Betrixaban Bevyxxa® An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Dabigatran Pradaxa® An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Dabigatran Etexilate An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Dalteparin Injection Fragmin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Edoxaban Savaysa An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Enoxaparin Lovenox An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Enoxaparin Injection Lovenox An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Fondaparinux Arixtra An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Fondaparinux Injection Arixtra An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Heparin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Heparin Injection Lipo-Hepin® An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage DetailsModerate
Lecanemab-Irmb Aspirin Acuprin® An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Aspirin Rectal Aspirin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Anagrelide Agrylin An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage Details Lecanemab-Irmb Clopidogrel Plavix An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage Details Lecanemab-Irmb Dipyridamole Permole® An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage Details Lecanemab-Irmb Epoprostenol Flolan An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage Details Lecanemab-Irmb Iloprost Aurlumyn An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.